FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasis

Infection

Volumn 41, Issue 5, 2013, Pages 1017-1019

  Kyrtatos, P G ^a   Debard, A ^b   Martin Blondel, G ^b,c   Alvarez, M ^b   Delobel, P ^b,c   Marchou, B ^b   Massip, P ^b   Wagner, T ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

FDG PET; FDG PET CT; Fever of unknown origin; HIV 1; Immune reconstitution inflammatory syndrome (IRIS); Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ATAZANAVIR; COTRIMOXAZOLE; EMTRICITABINE; FLUORODEOXYGLUCOSE F 18; RITONAVIR; TENOFOVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI VARICELLIFORM ERUPTION; LYMPHOMA; MAINTENANCE THERAPY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; VIREMIA; VIRUS LOAD; VISCERAL LEISHMANIASIS;

ADULT; FLUORODEOXYGLUCOSE F18; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEISHMANIASIS, VISCERAL; MALE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84885172552     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0459-2     Document Type: Article

References (14)

1. Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M; IeDEA Southern and Central Africa. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:251-61.
2. Berry A, Abraham B, Dereure J, Pinzani V, Bastien P, Reynes J. Two case reports of symptomatic visceral leishmaniasis in AIDS patients concomitant with immune reconstitution due to antiretroviral therapy. Scand J Infect Dis. 2004;36:225-7.
3. Lawn SD, Wilkinson RJ. Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. Parasite Immunol. 2006;28:625-33.
4. Castaigne C, Tondeur M, de Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun. 2009;30:41-7.
5. O'Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997;38:1575-83.
6. Mortensen BK, Nielsen SD, Christensen CB, Helweg-Larsen J. Immune reconstitution syndrome presenting as probable AIDS-related lymphoma: a case report. AIDS Res Ther. 2011;8:34.
7. Casabianca A, Marchetti M, Zallio F, Feyles E, Concialdi E, Ferroglio E, Biglino A. Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment. Infection. 2011;39:375-8.
8. Donati P, Paolino G, Panetta C, Muscardin L, Cota C, Giuliani M. Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient. Infection. 2013;41:575-8
9. del Giudice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty P, Gastaut JA, Costagliola D, Rosenthal E; French Hospital Database on HIV Clinical Epidemiologic Group. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis. 2002;186:1366-70.
10. Albrecht H. Leishmaniosis - new perspectives on an underappreciated opportunistic infection. AIDS. 1998;12:2225-6.
11. de la Rosa R, Pineda JA, Delgado J, Macías J, Morillas F, Martín-Sánchez J Leal M, Sánchez-Quijano A, Lissen E. Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect Dis. 2001;32:633-5.
12. Lupi A, Todeschini G, Zanco P. Diffuse metabolic activation of reticuloendothelium on F-18 FDG PET imaging in a case of visceral leishmania. Clin Nucl Med. 2006;31:34-6.
13. Yapar AF, Reyhan M, Kocer NE, Aydin M, Nursal GN. Diffuse splenic F-18 FDG uptake in visceral leishmaniasis. Clin Nucl Med. 2011;36:1041-3.
14. Sathekge M, Maes A, Kgomo M, Stoltz A, Van de Wiele C. Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis. J Nucl Med. 2011;52:880-5.